Loading clinical trials...
Loading clinical trials...
A Multicenter, Randomized, Double-Blind, Parallel, Active-controlled, Superiority, Phase III Clinical Trial to Evaluate the Efficacy and Safety of DW1601 Compared to DW16011 and DW16012 for Acute Bron...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Daewon Pharmaceutical Co., Ltd.
NCT07111468 · Acute Bronchitis
NCT07061925 · Acute Bronchitis
NCT07093697 · Acute Bronchitis
NCT06142994 · Acute Bronchitis
NCT05097677 · COVID-19 Pneumonia, COVID-19 Respiratory Infection, and more
Korea University Guro Hospital
Seoul
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions